Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models-Reference-Cited by-同舟云学术

Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models

Published:2015-04 Issue:4 Volume:212 Page:479.e1-479.e10
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Lengyel Ernst,Litchfield Lacey M.,Mitra Anirban K.,Nieman Kristin M.,Mukherjee Abir,Zhang Yilin,Johnson Alyssa,Bradaric Michael,Lee WooSeok,Romero Iris L.^ORCID

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference48 articles.

1. Estimating the cost of new drug development: Is it really 802 million dollars?;Adams;Health Aff (Millwood),2006

2. New uses for old drugs;Chong;Nature,2007

3. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin;Bowker;Diabetes Care,2006

4. Metformin and reduced risk of cancer in diabetic patients;Evans;Br Med J,2005

5. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes;Libby;Diabetes Care,2009

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the antitumor effects of metformin on ovarian clear cell carcinoma;Human Cell;2024-08-08

2. Drug Repositioning for Ovarian Cancer Treatment: An Update;Anti-Cancer Agents in Medicinal Chemistry;2024-05

3. Metformin: A Dual-Role Player in Cancer Treatment and Prevention;International Journal of Molecular Sciences;2024-04-06

4. Assessing the antitumor effects of metformin on ovarian clear cell carcinoma;2024-04-04

5. Metformin Loaded Zein Polymeric Nanoparticles to Augment Antitumor Activity against Ehrlich Carcinoma via Activation of AMPK Pathway: D-Optimal Design Optimization, In Vitro Characterization, and In Vivo Study;Molecules;2024-04-03